# Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV

> **NCT05413811** · NA · COMPLETED · sponsor: **UNC Lineberger Comprehensive Cancer Center** · enrollment: 180 (actual)

## Conditions studied

- Cervical Cancer
- CIN2
- CIN3
- Human Immunodeficiency Virus
- Human Papillomavirus

## Interventions

- **DRUG:** 5 Fluorouracil (5 FU) Cream
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05413811
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-22
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2026-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05413811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05413811, "Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05413811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*